Foresee doses first subject in Covid-19 ARDS treatment trial
Foresee Pharmaceuticals has started dosing patients in the Phase II/III clinical trial of its oral MMP-12 inhibitor, FP-025, to treat…
Taiwan (Province of China)
Latest in
Taiwan (Province of China)
Shionogi commences Phase I/II trial of Covid-19 vaccine candidate
Japanese company Shionogi has commenced Phase I/II clinical trial of a prophylactic Covid-19 vaccine candidate and administered the first dose.
GoldenBiotech reports positive data from leukaemia drug trial
Taiwanese biopharma company Golden Biotechnology (GoldenBiotech) has reported that data from its Phase IIa clinical study conducted in Russia showed…
Clinerion and PPC join forces on clinical trials acceleration
Clinical research services provider Clinerion has partnered with PPC to offer Patient Network Explorer services in South Korea, China and…
Lumosa to assess stroke drug in Phase II clinical trial
Taiwan-based Lumosa Therapeutics is set to launch a Phase II proof of concept clinical trial to evaluate its drug candidate…
I-Mab and MorphoSys begin Phase III study of blood cancer drug
Chinese clinical-stage biopharmaceutical company I-Mab Biopharma and German biotech company MorphoSys have begun the first dosed Phase III clinical study…
TWi Biotechnology completes enrolment in Phase II AC-203 trial
TWi Biotechnology (TWiB) has completed patient enrolment in a Phase II clinical trial of AC-203 for the treatment of inherited…
TLC completes enrolment in Phase I/II TLC590 trial
Taiwan Liposome Company (TLC) has completed patient enrolment in a Phase I/II clinical trial of TLC590 following inguinal hernia repair…